214 related articles for article (PubMed ID: 24898886)
1. Comparison of multiple DNA vaccines for protection against cytomegalovirus infection in BALB/c mice.
Huang C; Wang H; Wu S; Chang H; Liu L; Peng B; Fang F; Chen Z
Virol J; 2014 Jun; 11():104. PubMed ID: 24898886
[TBL] [Abstract][Full Text] [Related]
2. Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65).
Morello CS; Cranmer LD; Spector DH
J Virol; 2000 Apr; 74(8):3696-708. PubMed ID: 10729145
[TBL] [Abstract][Full Text] [Related]
3. Development of a vaccine against murine cytomegalovirus (MCMV), consisting of plasmid DNA and formalin-inactivated MCMV, that provides long-term, complete protection against viral replication.
Morello CS; Ye M; Spector DH
J Virol; 2002 May; 76(10):4822-35. PubMed ID: 11967299
[TBL] [Abstract][Full Text] [Related]
4. Immunization with cytomegalovirus envelope glycoprotein M and glycoprotein N DNA vaccines can provide mice with complete protection against a lethal murine cytomegalovirus challenge.
Wang H; Yao Y; Huang C; Chen Q; Chen J; Chen Z
Virol Sin; 2013 Jun; 28(3):174-82. PubMed ID: 23715998
[TBL] [Abstract][Full Text] [Related]
5. Strong CD8 T-cell responses following coimmunization with plasmids expressing the dominant pp89 and subdominant M84 antigens of murine cytomegalovirus correlate with long-term protection against subsequent viral challenge.
Ye M; Morello CS; Spector DH
J Virol; 2002 Mar; 76(5):2100-12. PubMed ID: 11836387
[TBL] [Abstract][Full Text] [Related]
6. Multiple epitopes in the murine cytomegalovirus early gene product M84 are efficiently presented in infected primary macrophages and contribute to strong CD8+-T-lymphocyte responses and protection following DNA immunization.
Ye M; Morello CS; Spector DH
J Virol; 2004 Oct; 78(20):11233-45. PubMed ID: 15452242
[TBL] [Abstract][Full Text] [Related]
7. Systemic priming-boosting immunization with a trivalent plasmid DNA and inactivated murine cytomegalovirus (MCMV) vaccine provides long-term protection against viral replication following systemic or mucosal MCMV challenge.
Morello CS; Ye M; Hung S; Kelley LA; Spector DH
J Virol; 2005 Jan; 79(1):159-75. PubMed ID: 15596812
[TBL] [Abstract][Full Text] [Related]
8. An adjuvanted inactivated murine cytomegalovirus (MCMV) vaccine induces potent and long-term protective immunity against a lethal challenge with virulent MCMV.
Wang H; Yao Y; Huang C; Fu X; Chen Q; Zhang H; Chen J; Fang F; Xie Z; Chen Z
BMC Infect Dis; 2014 Apr; 14():195. PubMed ID: 24720840
[TBL] [Abstract][Full Text] [Related]
9. High-frequency interferon-gamma-secreting splenocytes specific for murine cytomegalovirus immediate-early-1 (IE-1) peptide 168YPHFMPTNL176 are insufficient to provide complete protection from viral challenge.
Morley PJ; Ertl PF; Sweet C
J Med Virol; 2003 Feb; 69(2):240-50. PubMed ID: 12683414
[TBL] [Abstract][Full Text] [Related]
10. Dominant Antiviral CD8
Pardieck IN; van Duikeren S; Veerkamp DMB; Brasem DJ; Redeker A; van Bergen J; Han W; Ossendorp F; Zondag G; Arens R
Front Immunol; 2022; 13():680559. PubMed ID: 35154089
[TBL] [Abstract][Full Text] [Related]
11. A Live Olfactory Mouse Cytomegalovirus Vaccine, Attenuated for Systemic Spread, Protects against Superinfection.
Farrell HE; Bruce K; Stevenson PG
J Virol; 2021 Oct; 95(21):e0126421. PubMed ID: 34431701
[TBL] [Abstract][Full Text] [Related]
12. Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice.
Chiuppesi F; Nguyen J; Park S; Contreras H; Kha M; Meng Z; Kaltcheva T; Iniguez A; Martinez J; La Rosa C; Wussow F; Diamond DJ
J Virol; 2018 Oct; 92(19):. PubMed ID: 30045984
[TBL] [Abstract][Full Text] [Related]
13. DNA vaccine prime followed by boost with live attenuated virus significantly improves antigen-specific T cell responses against human cytomegalovirus.
Gil A; Shen S; Coley S; Gibson L; Diamond DJ; Wang S; Lu S
Hum Vaccin Immunother; 2013 Oct; 9(10):2120-32. PubMed ID: 24051429
[TBL] [Abstract][Full Text] [Related]
14. Complete protection of mice against lethal murine cytomegalovirus challenge by immunization with DNA vaccines encoding envelope glycoprotein complex III antigens gH, gL and gO.
Wang H; Huang C; Dong J; Yao Y; Xie Z; Liu X; Zhang W; Fang F; Chen Z
PLoS One; 2015; 10(3):e0119964. PubMed ID: 25803721
[TBL] [Abstract][Full Text] [Related]
15. DNA immunization confers protection against murine cytomegalovirus infection.
González Armas JC; Morello CS; Cranmer LD; Spector DH
J Virol; 1996 Nov; 70(11):7921-8. PubMed ID: 8892915
[TBL] [Abstract][Full Text] [Related]
16. A cytomegalovirus DNA vaccine induces antibodies that block viral entry into fibroblasts and epithelial cells.
McVoy MA; Lee R; Saccoccio FM; Hartikka J; Smith LR; Mahajan R; Wang JB; Cui X; Adler SP
Vaccine; 2015 Dec; 33(51):7328-7336. PubMed ID: 26597035
[TBL] [Abstract][Full Text] [Related]
17. Additive Protection against Congenital Cytomegalovirus Conferred by Combined Glycoprotein B/pp65 Vaccination Using a Lymphocytic Choriomeningitis Virus Vector.
Schleiss MR; Berka U; Watson E; Aistleithner M; Kiefmann B; Mangeat B; Swanson EC; Gillis PA; Hernandez-Alvarado N; Fernández-Alarcón C; Zabeli JC; Pinschewer DD; Lilja AE; Schwendinger M; Guirakhoo F; Monath TP; Orlinger KK
Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27795301
[TBL] [Abstract][Full Text] [Related]
18. Enveloped virus-like particle expression of human cytomegalovirus glycoprotein B antigen induces antibodies with potent and broad neutralizing activity.
Kirchmeier M; Fluckiger AC; Soare C; Bozic J; Ontsouka B; Ahmed T; Diress A; Pereira L; Schödel F; Plotkin S; Dalba C; Klatzmann D; Anderson DE
Clin Vaccine Immunol; 2014 Feb; 21(2):174-80. PubMed ID: 24334684
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity evaluation of DNA vaccines that target guinea pig cytomegalovirus proteins glycoprotein B and UL83.
Schleiss MR; Bourne N; Jensen NJ; Bravo F; Bernstein DI
Viral Immunol; 2000; 13(2):155-67. PubMed ID: 10892996
[TBL] [Abstract][Full Text] [Related]
20. A heterologous DNA prime/protein boost immunization strategy for rhesus cytomegalovirus.
Abel K; Strelow L; Yue Y; Eberhardt MK; Schmidt KA; Barry PA
Vaccine; 2008 Nov; 26(47):6013-25. PubMed ID: 18760319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
